A detailed history of Aptus Capital Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 4,532 shares of ZTS stock, worth $746,420. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,532
Previous 4,435 2.19%
Holding current value
$746,420
Previous $768,000 15.23%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$172.58 - $196.48 $16,740 - $19,058
97 Added 2.19%
4,532 $885,000
Q2 2024

Jul 31, 2024

BUY
$145.54 - $178.83 $24,159 - $29,685
166 Added 3.89%
4,435 $768,000
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $211,891 - $255,723
1,279 Added 42.78%
4,269 $722,000
Q4 2023

Feb 13, 2024

SELL
$151.44 - $200.09 $18,475 - $24,410
-122 Reduced 3.92%
2,990 $590,000
Q3 2023

Nov 08, 2023

BUY
$167.14 - $192.77 $230,987 - $266,408
1,382 Added 79.88%
3,112 $541,000
Q2 2023

Aug 11, 2023

SELL
$160.94 - $186.23 $281,484 - $325,716
-1,749 Reduced 50.27%
1,730 $297,000
Q1 2023

May 09, 2023

BUY
$145.48 - $175.02 $506,124 - $608,894
3,479 New
3,479 $579,000
Q2 2022

Jul 29, 2022

BUY
$155.97 - $200.09 $1.01 Million - $1.3 Million
6,494 Added 14.2%
52,211 $8.97 Million
Q1 2022

May 04, 2022

BUY
$181.39 - $234.03 $534,737 - $689,920
2,948 Added 6.89%
45,717 $8.62 Million
Q4 2021

Feb 02, 2022

BUY
$193.69 - $247.03 $4.34 Million - $5.54 Million
22,415 Added 110.13%
42,769 $10.4 Million
Q3 2021

Oct 27, 2021

BUY
$189.29 - $209.69 $789,907 - $875,036
4,173 Added 25.79%
20,354 $3.95 Million
Q2 2021

Jul 27, 2021

BUY
$155.9 - $187.99 $325,519 - $392,523
2,088 Added 14.82%
16,181 $3.02 Million
Q1 2021

May 06, 2021

BUY
$144.0 - $169.39 $101,376 - $119,250
704 Added 5.26%
14,093 $2.22 Million
Q4 2020

Feb 10, 2021

BUY
$157.07 - $174.35 $2.1 Million - $2.33 Million
13,389 New
13,389 $2.22 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.